Landen, Jaren W.

Effects of a NR2B selective NMDA glutamate antagonist, CP‐101,606, on dyskinesia and parkinsonism

Nutt, J. G., Gunzler, S. A., Kirchhoff, T., Hogarth, P., Weaver, J. L., Krams, M., Jamerson, B., Menniti, F. S., & Landen, J. W. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 133

Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer’s disease

Shulman, M., Wu, S., Ziogas, N., Edwards, A., Collins, J., Lin, L., Tien, I., Curiale, G., Li, Y., Mummery, C., et al. (2026) · Nature Aging

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 11